The Journal of Immunology, Vol 156, Issue 11 4476-4483, Copyright © 1996 by American Association of Immunologists

ARTICLES

Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation

TD Barker, D Weissman, JA Daucher, KM Roche and AS Fauci
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Using an in vitro model system that reflects the cellular interactions occurring in the microenvironment of lymphoid organs (i.e., the interaction between dendritic cells (DC) and CD4+ T lymphocytes), the ability of CD8+ T cells to inhibit HIV replication was investigated. DC, the most potent APC in the paracortical region of lymphoid organs, were cocultured with autologous, unstimulated CD4+ T cells resulting in viral replication in the absence of exogenous stimulation. Using two variations of DC cocultures, one an acute infection system and the other an endogenous infection system, two sets of activities were identified. One activity was expressed in both HIV-infected and - uninfected individuals, and a second was found only in HIV-infected individuals. These activities can be differentiated further by their evolution or lack thereof with disease progression in infected individuals and their sensitivity to gamma irradiation. Furthermore, the results indicate that CD8+ T cell modulation of HIV replication in CD4+ T cells is a multifactorial phenomenon involving both inhibitory and stimulatory effects on HIV replication.

This article has been cited by other articles:

				J. Zhao, J. Pinczewski, V. R. Gomez-Roman, D. Venzon, V. S. Kalyanaraman, P. D. Markham, K. Aldrich, M. Moake, D. C. Montefiori, Y. Lou, et al. Improved Protection of Rhesus Macaques against Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge by a Replication-Competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag Recombinant Priming/gp120 Boosting Regimen J. Virol., August 1, 2003; 77(15): 8354 - 8365. [Abstract] [Full Text] [PDF]

				C. M. Hogan and S. M. Hammer Host Determinants in HIV Infection and Disease: Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics Ann Intern Med, May 15, 2001; 134(10): 978 - 996. [Abstract] [Full Text] [PDF]

				D. Scales, H. Ni, F. Shaheen, J. Capodici, G. Cannon, and D. Weissman Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation J. Immunol., May 15, 2001; 166(10): 6437 - 6443. [Abstract] [Full Text] [PDF]

				M. E. Severino, N. V. Sipsas, P. T. Nguyen, S. A. Kalams, B. D. Walker, R. P. Johnson, and O. O. Yang Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary CD4+ T Lymphocytes, Monocytes, and Dendritic Cells by Cytotoxic T Lymphocytes J. Virol., July 15, 2000; 74(14): 6695 - 6699. [Abstract] [Full Text]

				J. C. L. B. de Quiros, W. L. Shupert, A. C. McNeil, J. C. Gea-Banacloche, M. Flanigan, A. Savage, L. Martino, E. E. Weiskopf, H. Imamichi, Y.-M. Zhang, et al. Resistance to Replication of Human Immunodeficiency Virus Challenge in SCID-Hu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+ T Cells and Associated with a Proliferative Response to p24 Antigen J. Virol., February 15, 2000; 74(4): 2023 - 2028. [Abstract] [Full Text]

				C. E. Mackewicz, M. R. Garovoy, and J. A. Levy HLA Compatibility Requirements for CD8+-T-Cell-Mediated Suppression of Human Immunodeficiency Virus Replication J. Virol., December 1, 1998; 72(12): 10165 - 10170. [Abstract] [Full Text] [PDF]

				R. Ciubotariu, A. I. Colovai, G. Pennesi, Z. Liu, D. Smith, P. Berlocco, R. Cortesini, and N. Suciu-Foca Specific Suppression of Human CD4+ Th Cell Responses to Pig MHC Antigens by CD8+CD28- Regulatory T Cells J. Immunol., November 15, 1998; 161(10): 5193 - 5202. [Abstract] [Full Text] [PDF]

				R. Pal, A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico Inhibition of HIV-1 Infection by the -Chemokine MDC Science, October 24, 1997; 278(5338): 695 - 698. [Abstract] [Full Text]